These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37130545)

  • 1. Algorithm for optimized mRNA design improves stability and immunogenicity.
    Zhang H; Zhang L; Lin A; Xu C; Li Z; Liu K; Liu B; Ma X; Zhao F; Jiang H; Chen C; Shen H; Li H; Mathews DH; Zhang Y; Huang L
    Nature; 2023 Sep; 621(7978):396-403. PubMed ID: 37130545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial settles debate over best design for mRNA in COVID vaccines.
    Dolgin E
    Nature; 2023 Jan; 613(7944):419-420. PubMed ID: 36639446
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for Strong Mutation Bias toward, and Selection against, U Content in SARS-CoV-2: Implications for Vaccine Design.
    Rice AM; Castillo Morales A; Ho AT; Mordstein C; Mühlhausen S; Watson S; Cano L; Young B; Kudla G; Hurst LD
    Mol Biol Evol; 2021 Jan; 38(1):67-83. PubMed ID: 32687176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
    Gebre MS; Rauch S; Roth N; Yu J; Chandrashekar A; Mercado NB; He X; Liu J; McMahan K; Martinot A; Martinez DR; Giffin V; Hope D; Patel S; Sellers D; Sanborn O; Barrett J; Liu X; Cole AC; Pessaint L; Valentin D; Flinchbaugh Z; Yalley-Ogunro J; Muench J; Brown R; Cook A; Teow E; Andersen H; Lewis MG; Boon ACM; Baric RS; Mueller SO; Petsch B; Barouch DH
    Nature; 2022 Jan; 601(7893):410-414. PubMed ID: 34794169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addressing the Cold Reality of mRNA Vaccine Stability.
    Crommelin DJA; Anchordoquy TJ; Volkin DB; Jiskoot W; Mastrobattista E
    J Pharm Sci; 2021 Mar; 110(3):997-1001. PubMed ID: 33321139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development.
    Wu X; Shan KJ; Zan F; Tang X; Qian Z; Lu J
    Adv Sci (Weinh); 2023 Aug; 10(23):e2205445. PubMed ID: 37267926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical basis for stabilizing messenger RNA through secondary structure design.
    Wayment-Steele HK; Kim DS; Choe CA; Nicol JJ; Wellington-Oguri R; Watkins AM; Parra Sperberg RA; Huang PS; Participants E; Das R
    Nucleic Acids Res; 2021 Oct; 49(18):10604-10617. PubMed ID: 34520542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
    Hansen CB; Jarlhelt I; Hasselbalch RB; Hamm SR; Fogh K; Pries-Heje MM; Møller DL; Heftdal LD; Pérez-Alós L; Sørensen E; Larsen MAH; Skjoedt MO; Ostrowski SR; Frikke-Schmidt R; Bayarri-Olmos R; Hilsted LM; Bundgaard H; Nielsen SD; Iversen KK; Garred P
    J Intern Med; 2021 Dec; 290(6):1272-1274. PubMed ID: 34237190
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection.
    Gobbi F; Buonfrate D; Moro L; Rodari P; Piubelli C; Caldrer S; Riccetti S; Sinigaglia A; Barzon L
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2.
    Huang Q; Ji K; Tian S; Wang F; Huang B; Tong Z; Tan S; Hao J; Wang Q; Tan W; Gao GF; Yan J
    Nat Commun; 2021 Feb; 12(1):776. PubMed ID: 33536425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis.
    Molica S; Giannarelli D; Montserrat E
    Eur J Haematol; 2022 Mar; 108(3):264-267. PubMed ID: 34856031
    [No Abstract]   [Full Text] [Related]  

  • 13. Are There Hidden Genes in DNA/RNA Vaccines?
    Beaudoin CA; Bartas M; Volná A; Pečinka P; Blundell TL
    Front Immunol; 2022; 13():801915. PubMed ID: 35211117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates.
    Zhao H; Wang TC; Li XF; Zhang NN; Li L; Zhou C; Deng YQ; Cao TS; Yang G; Li RT; Huang YJ; Li YG; Zhang YM; Li FX; Zhou YR; Jiang YH; Lu XS; Sun SH; Cheng ML; Gu KP; Zhang M; Ma QQ; Yang X; Ying B; Gao YW; Qin CF
    Signal Transduct Target Ther; 2021 Dec; 6(1):438. PubMed ID: 34952914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
    O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
    Front Immunol; 2021; 12():800723. PubMed ID: 34992610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series.
    Danese E; Montagnana M; Salvagno GL; Peserico D; Pighi L; De Nitto S; Henry BM; Porru S; Lippi G
    Clin Chem Lab Med; 2021 Aug; 59(9):1585-1591. PubMed ID: 33838087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19.
    Kackos CM; Surman SL; Jones BG; Sealy RE; Jeevan T; Davitt CJH; Pustylnikov S; Darling TL; Boon ACM; Hurwitz JL; Samsa MM; Webby RJ
    Microbiol Spectr; 2023 Feb; 11(1):e0424022. PubMed ID: 36695597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From mRNA sensing to vaccines.
    Fauci AS; Merad M; Swaminathan S; Hur S; Topol E; Fitzgerald K; Reis e Sousa C; Corbett KS; Bauer S
    Immunity; 2021 Dec; 54(12):2676-2680. PubMed ID: 34739870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera.
    Seephetdee C; Bhukhai K; Buasri N; Leelukkanaveera P; Lerdwattanasombat P; Manopwisedjaroen S; Phueakphud N; Kuhaudomlarp S; Olmedillas E; Saphire EO; Thitithanyanont A; Hongeng S; Wongtrakoongate P
    Antiviral Res; 2022 Aug; 204():105370. PubMed ID: 35772601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters.
    Lu M; Zhang Y; Dravid P; Li A; Zeng C; Kc M; Trivedi S; Sharma H; Chaiwatpongsakorn S; Zani A; Kenney A; Cai C; Ye C; Liang X; Qiu J; Martinez-Sobrido L; Yount JS; Boyaka PN; Liu SL; Peeples ME; Kapoor A; Li J
    J Virol; 2021 Sep; 95(20):e0059221. PubMed ID: 34379509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.